A New Diagnostic Method to Assess Paclitaxel-Induced Peripheral Neuropathy
NCT04237194 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 20
Last updated 2022-08-24
Summary
To assess the impact of Paclitaxel treatment on the nerve excitability of the small and large nerve fibers
Conditions
- Chemotherapy-induced Peripheral Neuropathy
Sponsors & Collaborators
-
Aalborg University Hospital
collaborator OTHER -
Carsten Dahl Mørch
lead OTHER
Principal Investigators
-
Laurids Ø Poulsen, MD, PhD · Aalborg University Hospital
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-09-01
- Primary Completion
- 2023-12-30
- Completion
- 2024-06-30
Countries
- Denmark
Study Locations
More Related Trials
-
A Multicenter, Randomized, Double-blind Phase II Trial to Evaluate GM1 Prevention of Peripheral Neuropathy in Patients With Breast Cancer
NCT05802342 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3
-
The Potential of HemoScreen for Monitoring Blood Values in Cancer Patients at Home
NCT04543734 ·Status: COMPLETED
-
Treatment of Anemia in Subjects With Non-Myeloid Malignancy Receiving Multicycle Chemotherapy
NCT00110955 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Neutropenia and Anemia Management in Patients With Solid Tumors Receiving Myelotoxic Chemotherapy
NCT00883181 ·Status: COMPLETED
-
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
NCT00858364 ·Status: TERMINATED ·Phase: PHASE3
-
Self Reported Pain in Women While Undergoing Treatment for Non-metastatic Breast Cancer
NCT04174742 ·Status: ACTIVE_NOT_RECRUITING
-
Predictive Value of ProCalcitonin for the Detection of Bacteraemia in Patients Presenting to the Emergency Department for Low Risk Chemo-induced Febrile Neutropenia
NCT03182465 ·Status: TERMINATED ·Phase: NA
-
Peripheral Blood CD34-positive Cells Enumeration as Predictor of Stem Cell Harvest
NCT02023814 ·Status: COMPLETED
-
A Study of Darbepoetin Alfa for the Treatment of Anemia in Subjects With a Non-Myeloid Malignancy
NCT00117624 ·Status: COMPLETED ·Phase: PHASE3
-
Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors
NCT00014456 ·Status: COMPLETED ·Phase: PHASE1
-
Distinction Risk of Severe Infection in Febrile Neutropenia After Chemotherapy
NCT03434795 ·Status: COMPLETED
-
Study for the Treatment of Anemia in Patients With Non-myeloid Malignancies Receiving Multicycle Chemotherapy.
NCT00148421 ·Status: COMPLETED ·Phase: PHASE3
-
Plinabulin iv Solution in Prevention of TAC Induced Neutropenia
NCT04227990 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy, Safety and Cost-effectiveness of PEG-rhG-CSF for Primary vs Secondary Prophylaxis
NCT03701841 ·Status: UNKNOWN
-
Efficacy of Lithium Against Chemotherapy Induced Neutropenia in Breast Cancer Patients
NCT05221593 ·Status: COMPLETED ·Phase: PHASE3
-
Farnesyl Protein Transferase Inhibitor (FPTI) in Combination With Docetaxel in Advanced Solid Tumors (Study P01964)(COMPLETED)
NCT00040547 ·Status: COMPLETED ·Phase: PHASE1
-
Study on the Incidence of Febrile Episodes During Stem Cells Collection After Chemotherapy in Patients With Multiple Myeloma
NCT00932217 ·Status: UNKNOWN ·Phase: PHASE3
-
Study to Develop a Screening Tool for Functional Capacity in Anemic Subjects With Nonmyeloid Malignancies Receiving Chemotherapy and Darbepoetin Alfa
NCT00540696 ·Status: COMPLETED ·Phase: PHASE2
-
The Oral Cavity as a Source of Febrile Neutropenia
NCT02702583 ·Status: COMPLETED
-
Evaluating Treatment of Anemia in Subjects With Non-Myeloid MalignanciesReceiving Multicycle Chemotherapy
NCT00111462 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Carboplatin/Paclitaxel With Pegfilgrastim Supported by Haematopoietic Progenitor Cell Re-Infusion in Whole Blood
NCT00117442 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Darbepoetin Alfa in Anemic Subjects Not Receiving Chemotherapy Who Have Completed the 20010103 Study
NCT00115167 ·Status: COMPLETED ·Phase: PHASE3
-
A Novel Erythropoiesis Stimulating Protein (NESP; Darbopoetin Alfa) for the Treatment of Anemia in Lung Cancer Patients Receiving Multi-cycle Platinum-Containing Chemotherapy
NCT03776032 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Iron Supplementation During Darbepoetin Alfa Treatment in Prophylaxis of Severe Anaemia Chemo-Induced
NCT00210002 ·Status: TERMINATED ·Phase: PHASE2
-
Prophylaxis of Febrile Neutropenia With Lactoferrin in Oncohematologic Children Undergoing Induction Chemotherapy
NCT07113314 ·Status: COMPLETED ·Phase: NA